Gainers

HeartBeam, Inc. (NASDAQ:BEAT) shares jumped 85.6% to close at $2.32 on Thursday after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO. NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) rose 47.2% to close at $24.82 after the company announced Dong-A has licensed its global exclusive development rights of DA-1241 for type 2 diabetes and non-alcoholic fatty hepatitis and DA-1726 for obesity and non-alcoholic fatty hepatitis to NeuroBo. Nabriva Therapeutics plc (NASDAQ:NBRV) climbed 39.4% to close at $0.2671 after the company announced it will effect a 1-for...